glp 1 bipolar disorder Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in disorder: a narrative review of preclinical and clinical evidence Glucagon-like peptide-1 medicines in neurological

Recent studies suggest that Ozempic (semaglutide) and other glucagon-like peptide-1 (GLP-1) agonists may have anti-inflammatory effects in addition to their approved use for diabetes

By introducing new medications and forming collaborations with different caregivers, weve seen real results people feel better and avoid hospitalizations, said Tony Bashall, MD, an Indianapolis cardiologist at Franciscan Health Indiana Heart Physicians with an interest in cardiometabolic health

Cyrus Sedaghat can recommend a stepwise plan that may include nutrition targets, activity guidance, and a dosing schedule that is adjusted based on tolerance and results

Expert-led care: Providers adjust your dose, manage side effects, and tailor treatment to your health history

C., Chou, V